Sugandha Ravishankar
QIMR Berghofer Medical Research Institute(AU)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Protein Degradation and Inhibitors, Computational Drug Discovery Methods, Synthesis and biological activity, Advanced Breast Cancer Therapies
Most-Cited Works
- → Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2010)261 cited
- → Disease-specific, neurosphere-derived cells as models for brain disorders(2010)193 cited
- → NRF2 Activation Restores Disease Related Metabolic Deficiencies in Olfactory Neurosphere-Derived Cells from Patients with Sporadic Parkinson's Disease(2011)136 cited
- → Variability in the Generation of Induced Pluripotent Stem Cells: Importance for Disease Modeling(2012)84 cited
- → DNA methylation in schizophrenia in different patient-derived cell types(2017)28 cited
- → Murine Neonatal Melanocytes Exhibit a Heightened Proliferative Response to Ultraviolet Radiation and Migrate to the Epidermal Basal Layer(2008)2 cited
- → Supplementary Figure 3 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)
- → Supplementary Figures 8-12 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)
- → Supplementary Table 6 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)
- → Supplementary Table 5 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)